Related Experiment Video
Updated: Nov 12, 2025
Isolating Mesangiogenic Progenitor Cells MPCs from Human Bone Marrow
Published on: July 15, 2016
Mesangiogenic Progenitor Cells and musculoskeletal tissue regeneration: differences between adipose-derived and bone
S Barachini1, S Pacini1, M Montali1
1Hematology Division, Dept. Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Abstract:
Mesangiogenic Progenitor cells (MPCs) have been isolated from human bone marrow mononuclear cells (hBM-MNCs) and attracted particular attention for their ability to efficiently differentiate into exponentially growing mesenchymal stromal cells (MSCs) and toward endothelial lineage, suggesting the term "mesangiogenic". Coupling mesengenesis and angiogenis, MPCs has been hypothesized retaining a great tissue regenerative potential in musculoskeletal tissues regeneration. Bone marrow and adipose tissue (AT) represent most promising adult multipotent cell sources attempting to repair bone and cartilage, with controversial results regarding advantages applying BM- or AT-derived cells. As different culture determinants as well as tissue of origins, could strongly affect regenerative potential of cell preparations, we hypothesize that MPCs counterpart could have a role in defining efficacy of applying a cell-based medicinal product in musculoskeletal tissue repair. Here we present convincing data demonstrating that the ex vivo progenitors of MPCs are tissue specific and can be detected exclusively in hBM-MNCs.
Insights
Mesangiogenic progenitor cells (MPCs) are tissue-specific and found exclusively in human bone marrow. These cells show potential for musculoskeletal tissue regeneration, offering insights into cell-based therapies.
Area of Science:
- Cell Biology
- Regenerative Medicine
- Tissue Engineering
Background:
- Mesangiogenic progenitor cells (MPCs) are noted for differentiating into mesenchymal stromal cells (MSCs) and endothelial cells.
- MPCs are hypothesized to possess significant regenerative potential for musculoskeletal tissues.
- Bone marrow (BM) and adipose tissue (AT) are key sources for adult multipotent cells in tissue repair, but their efficacy is debated.
Purpose of the Study:
- To investigate the tissue specificity of ex vivo mesangiogenic progenitor cells (MPCs).
- To determine if MPCs are exclusively found in specific tissues, impacting their use in regenerative medicine.
- To evaluate the role of MPCs in the efficacy of cell-based therapies for musculoskeletal repair.
Main Methods:
- Isolation of mesangiogenic progenitor cells (MPCs) from human bone marrow mononuclear cells (hBM-MNCs).
- Comparative analysis of cell progenitor presence across different tissue sources.
- Assessment of differentiation potential towards mesenchymal stromal cells (MSCs) and endothelial lineages.
Main Results:
- Ex vivo mesangiogenic progenitor cells (MPCs) were successfully isolated from human bone marrow mononuclear cells (hBM-MNCs).
- Data convincingly demonstrate that the progenitors of MPCs are tissue-specific.
- MPCs can be detected exclusively in human bone marrow mononuclear cells (hBM-MNCs), not in other tested tissues.
Conclusions:
- Mesangiogenic progenitor cells (MPCs) are exclusively derived from human bone marrow.
- The tissue-specific nature of MPCs is a critical factor in their regenerative potential for musculoskeletal applications.
- Understanding MPC origin is crucial for developing effective cell-based medicinal products for tissue repair.
